Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease

被引:8
作者
Adnan, Yasir [1 ]
Noor, Lubna [2 ]
Dar, Muhammad Habeel [2 ]
Ali, Umair [2 ]
Hafizullah, Muhammad [2 ]
机构
[1] Police & Serv Hosp, Dept Cardiol, Peshawar, Pakistan
[2] Lady Reading Hosp, Dept Cardiol, Peshawar, Pakistan
关键词
Coronary Artery Disease; Drug Eluting stent; Exercise Tolerance Test; BARE METAL STENTS; RESTENOSIS; RISK; IMPLANTATION; ANGIOPLASTY; ANGIOGRAPHY; PREDICTORS; THROMBOSIS; TRIAL;
D O I
10.12669/pjms.334.13068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background & Objective: The risk of restenosis and other adverse cardiovascular events with bare-metal stents have increased with smaller stent diameters and longer stent lengths. However, the exact impact of stent size on the short-term outcomes of drug-eluting stent (DES) implantations has not been much classified in Pakistani population. This study was designed to evaluate the impact of size (length and diameter) of Drug Eluting Stents on Clinical outcomes in patient with stable coronary artery disease at three months of implantation in Pakistani Population. Methods: This is a prospective study which was carried out in the Department of Cardiology, Lady Reading Hospital Peshawar from April 2011 and July 2012. All consecutive patients with stable coronary disease undergoing Percutaneous Intervention (PCI) with DES implantation at Cardiology Unit Lady Reading Hospital, were included prospectively. Clinical outcomes (Myocardial infarction [MI], unstable angina[UA], and positive ETT) at three months stratified by 3 tertiles of stent length and diameter each, were measured in patients who underwent PCI with DES for coronary artery lesions. All patients were followed and reassessed after three months from the index procedure. Exercise Tolerance Test (ETT) was performed on every patient and recorded on proforma. Data analysis was done using SPSS software version 16. Results: A total of 376 patients were included prospectively in this study. The mean age was 57 +/- 9.313 years. Male patients were 271(72.1%). Mean length of drug eluting stent was 27.313 +/- 7.235 mm while mean diameter of stent was 2.90 +/- 0.2483mm. There were slightly higher rates of MI, U.A and positive ETT in the longest stent length tertile (>28mm) compared with the shortest stent length tertile (<22mm) at three months, but they were statistically not significant. We also observed that for DES, there was no clear relationship between stent diameter and outcome for any of the clinical outcome variables. Conclusion: In our single-center prospective study, stent length and diameter defined in tertiles, had no impact on the short-term clinical outcomes of DES in patients with stable coronary artery disease.
引用
收藏
页码:959 / 962
页数:4
相关论文
共 19 条
[1]   The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial [J].
Boden, William E. ;
O'Rourke, Robert A. ;
Teo, Koon K. ;
Hartigan, Pamela M. ;
Maron, David J. ;
Kostuk, William ;
Knudtson, Merril ;
Dada, Marcin ;
Casperson, Paul ;
Harris, Crystal L. ;
Spertus, John A. ;
Shaw, Leslee ;
Chaitman, Bernard R. ;
Mancini, John ;
Berman, Daniel S. ;
Gau, Gerald ;
Weintraub, William S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (02) :208-212
[2]   CLINICAL, PHYSIOLOGICAL, ANATOMIC AND PROCEDURAL FACTORS PREDICTIVE OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
BOURASSA, MG ;
LESPERANCE, J ;
EASTWOOD, C ;
SCHWARTZ, L ;
COTE, G ;
KAZIM, F ;
HUDON, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :368-376
[3]   Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography [J].
Cassese, Salvatore ;
Byrne, Robert A. ;
Tada, Tomohisa ;
Pinieck, Susanne ;
Joner, Michael ;
Ibrahim, Tareq ;
King, Lamin A. ;
Fusaro, Massimiliano ;
Laugwitz, Karl-Ludwig ;
Kastrati, Adnan .
HEART, 2014, 100 (02) :153-159
[4]   Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TB [J].
Chang, Suzanne W. ;
Pan, William S. ;
Lozano Beltran, Daniel ;
Oleyda Baldelomar, Lizet ;
Antonio Solano, Marco ;
Tuero, Iskra ;
Friedland, Jon S. ;
Torrico, Faustino ;
Gilman, Robert H. .
PLOS ONE, 2013, 8 (01)
[5]   Drug-eluting stents perform better than bare metal stents in small coronary vessels: A meta-analysis of randomised and observational clinical studies with mid-term follow up [J].
Cortese, Bernardo ;
Bertoletti, Alessandra ;
De Matteis, Sara ;
Danzi, Gian Battista ;
Kastrati, Adnan .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 161 (02) :73-82
[6]   Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography [J].
de Feyter, PJ ;
Kay, P ;
Disco, C ;
Serruys, PW .
CIRCULATION, 1999, 100 (17) :1777-1783
[7]   Vessel size and long-term outcome after coronary stent placement [J].
Elezi, S ;
Kastrati, A ;
Neumann, FJ ;
Hadamitzky, M ;
Dirschinger, J ;
Schömig, A .
CIRCULATION, 1998, 98 (18) :1875-1880
[8]   The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions - Final results of the Magic 5L Study [J].
Foley, DP ;
Pieper, M ;
Wijns, W ;
Suryapranata, H ;
Grollier, G ;
Legrand, V ;
de Scheerder, I ;
Hanet, C ;
Puel, J ;
Mudra, H ;
Bonnier, HJRM ;
Colombo, A ;
Thomas, M ;
Probst, P ;
Morice, MC ;
Kleijne, J ;
Serruys, PW .
EUROPEAN HEART JOURNAL, 2001, 22 (17) :1585-1593
[9]   RESTENOSIS AFTER CORONARY ANGIOPLASTY - A MULTIVARIATE STATISTICAL-MODEL TO RELATE LESION AND PROCEDURE VARIABLES TO RESTENOSIS [J].
HIRSHFELD, JW ;
SCHWARTZ, JS ;
JUGO, R ;
MACDONALD, RG ;
GOLDBERG, S ;
SAVAGE, MP ;
BASS, TA ;
VETROVEC, G ;
COWLEY, M ;
TAUSSIG, AS ;
WHITWORTH, HB ;
MARGOLIS, JR ;
HILL, JA ;
PEPINE, CJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (03) :647-656
[10]   Analysis of 1-year clinical outcomes in the SIRIUS trial - A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis [J].
Holmes, DR ;
Leon, MB ;
Moses, JW ;
Popma, JJ ;
Cutlip, D ;
Fitzgerald, PJ ;
Brown, C ;
Fischell, T ;
Wong, SC ;
Midei, M ;
Snead, D ;
Kuntz, RE .
CIRCULATION, 2004, 109 (05) :634-640